'Inhalation Drug Delivery', Berlin, Germany
Research in the area of pulmonary drug delivery has gathered momentum over the last few years with increased interest in using the lung as a means of delivering drugs. This approach has a faster therapeutic effect and reduced side effects associated with alternative methods of drug delivery.
The conference focuses on the trends in the development and formulation of orally inhaled products. Areas of discussion include manufacturing and commercialisation, clinical trial assessments and inhalation device technology.
The event will bring together clinicians and pharma groups to discuss the latest findings in nasal drug delivery systems and examine the obstacles of effective formulation of nasal products.For further information, please visit:
http://www.cphi-drugdelivery.com/(opens in new window)